Weekly HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Ratings as of Jun 27, 2018

June 27, 2018 - By Mohammad Shatley

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Corporate Logo

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Ratings Coverage

In total 2 analysts cover HTG Molecular Diagnostics (NASDAQ:HTGM). “Buy” rating has 2, “Sell” are 0, while 0 are “Hold”. 100% are bullish. 11 are the (NASDAQ:HTGM)’s analyst reports since January 5, 2018 according to StockzIntelligence Inc. On Friday, January 5 the stock has “Buy” rating by H.C. Wainwright. On Tuesday, May 8 H.C. Wainwright maintained HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) with “Buy” rating. On Monday, January 8 the stock of HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) has “Buy” rating given by Canaccord Genuity. In Tuesday, May 22 report H.C. Wainwright maintained it with “Buy” rating and $700 target. On Thursday, February 1 the firm has “Buy” rating given by H.C. Wainwright. In Friday, March 23 report H.C. Wainwright maintained it with “Buy” rating and $700 target. On Wednesday, January 24 H.C. Wainwright maintained HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) with “Buy” rating. On Friday, January 5 Canaccord Genuity maintained HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) with “Buy” rating. On Friday, March 23 the rating was maintained by Canaccord Genuity with “Buy”. The stock rating was maintained by H.C. Wainwright with “Buy” on Tuesday, April 17. Listed here are HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) PTs and latest ratings.

08/06/2018 Broker: H.C. Wainwright Rating: Buy New Target: $7.0000 Maintain
22/05/2018 Broker: H.C. Wainwright Rating: Buy New Target: $7.0000 Maintain
08/05/2018 Broker: H.C. Wainwright Rating: Buy New Target: $7.0000 Maintain
17/04/2018 Broker: H.C. Wainwright Rating: Buy New Target: $7.0000 Maintain
23/03/2018 Broker: Canaccord Genuity Old Rating: Buy New Rating: Buy Old Target: $5 New Target: $7 Maintain
23/03/2018 Broker: H.C. Wainwright Rating: Buy New Target: $7.0000 Maintain
01/02/2018 Broker: H.C. Wainwright Rating: Buy New Target: $6.0 Maintain
24/01/2018 Broker: H.C. Wainwright Rating: Buy New Target: $6.0 Maintain
08/01/2018 Broker: Canaccord Genuity Rating: Buy New Target: $5.0 Maintain
05/01/2018 Broker: Canaccord Genuity Rating: Buy New Target: $5.0 Maintain

HTGM hit $3.325 during the last trading session after $0.055 change.Currently HTG Molecular Diagnostics, Inc. is uptrending after 3.13% change in last June 27, 2017. HTGM has also 149,326 shares volume. The stock underperformed the S&P 500 by 9.44%.

HTG Molecular Diagnostics, Inc. develops and markets services and products based on proprietary technology that facilitates the routine use of targeted molecular profiling.The firm is valued at $94.33 million. The companyÂ’s products, HTG Edge and HTG EdgeSeq platforms include instrumentation , consumables comprising assay kits, and software analytics that automate sample processing and profiles various molecular targets from samples a fraction of the size required by prevailing technologies.Last it reported negative earnings. The Company’s platforms generate a molecular profiling library for detection using next-generation sequencing.

There’s a substantial HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) news announced by Seekingalpha.com. It’s a report titled: “HTG Molecular: Entering Stage Of Growth And Momentum” on June 11, 2018.

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: